Observational analyses from ADVANCE and ADVANCE‐ON (Englisch)
- Neue Suche nach: Chalmers, John
- Neue Suche nach: Woodward, Mark
- Neue Suche nach: Chalmers, John
- Neue Suche nach: Woodward, Mark
In:
Diabetes, Obesity and Metabolism
;
22
;
19-32
;
2020
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Observational analyses from ADVANCE and ADVANCE‐ON
-
Beteiligte:Chalmers, John ( Autor:in ) / Woodward, Mark ( Autor:in )
-
Erschienen in:Diabetes, Obesity and Metabolism ; 22 ; 19-32
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.04.2020
-
Format / Umfang:14 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 22
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Issue Information| 2020
- 1
-
Diabetes, Obesity and Metabolism| 2020
- 3
-
Cardiovascular outcomes trials in type 2 diabetes: Time to include young adultsKe, Calvin / Shah, Baiju R. / Luk, Andrea O. / Di Ruggiero, Erica / Chan, Juliana C. N. et al. | 2020
- 3
-
ADVANCEMatthews, David R. et al. | 2020
- 3
-
An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelinesSelby, Nicholas M. / Taal, Maarten W. et al. | 2020
- 3
-
Efficacy and safety of insulin glargine/lixisenatide fixed‐ratio combination (iGlarLixi) in Japanese patients with type 2 diabetes mellitus inadequately controlled on basal insulin and oral antidiabetic drugs: The LixiLan JP‐L randomized clinical trialKaneto, Hideaki / Takami, Akane / Spranger, Robert / Amano, Atsushi / Watanabe, Daisuke / Niemoeller, Elisabeth et al. | 2020
- 5
-
ADVANCE in context: The benefits, risks and feasibility of providing intensive glycaemic control based on gliclazide modified releaseZoungas, Sophia et al. | 2020
- 6
-
Diabetes drugs and stroke risk: Intensive versus conventional glucose‐lowering strategies, and implications of recent cardiovascular outcome trialsLim, Soo / Oh, Tae Jung / Dawson, Jesse / Sattar, Naveed et al. | 2020
- 12
-
Renal protection: What have we learnt from ADVANCE about kidney disease in type 2 diabetes?Knudsen, Søren T. / Cooper, Mark E. et al. | 2020
- 14
-
Efficacy and safety of insulin glargine/lixisenatide fixed‐ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26‐week, open‐label, multicentre study: The LixiLan JP‐O2 randomized clinical trialTerauchi, Yasuo / Nakama, Takahiro / Spranger, Robert / Amano, Atsushi / Inoue, Takahiro / Niemoeller, Elisabeth et al. | 2020
- 16
-
Effects of sodium‐glucose cotransporter‐2 inhibitors on the cardiovascular and renal complications of type 2 diabetesChilton, Robert J. et al. | 2020
- 16
-
Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targetsBarrera‐Chimal, Jonatan / Jaisser, Frédéric et al. | 2020
- 19
-
Observational analyses from ADVANCE and ADVANCE‐ONChalmers, John / Woodward, Mark et al. | 2020
- 24
-
Fixed‐ratio combination of basal insulin and glucagon‐like peptide‐1 receptor agonists in the treatment of Japanese people with type 2 diabetes: An innovative solution to a complex therapeutic challengeKaneto, Hideaki / Koshida, Ryusuke / Baxter, Mike et al. | 2020
- 30
-
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trialKoomen, Jeroen V. / Heerspink, Hiddo J. L. / Schrieks, Ilse C. / Schwartz, Gregory G. / Lincoff, A. Michael / Nicholls, Stephen J. / Svensson, Anders / Wedel, Hans / Weichert, Arlette / Grobbee, Diederick E. et al. | 2020
- 32
-
Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal riskStephens, Jeffrey W. / Brown, Karen E. / Min, Thinzar et al. | 2020
- 33
-
Importance of intensive blood pressure control in type 2 diabetes: Mechanisms, treatments and current guidelinesMarre, Michel et al. | 2020
- 35
-
Benefits of the fixed‐ratio combination of insulin glargine 100 units/mL and lixisenatide (iGlarLixi) in Japanese people with type 2 diabetes: A subgroup and time‐to‐control analysis of the LixiLan JP phase 3 trialsTerauchi, Yasuo / Yabe, Daisuke / Kaneto, Hideaki / Amano, Atsushi / Baxter, Mike / Watanabe, Daisuke / Watada, Hirotaka / Inagaki, Nobuya et al. | 2020
- 39
-
Systematic literature review and network meta‐analysis of sodium‐glucose co‐transporter inhibitors vs metformin as add‐on to insulin in type 1 diabetesLangford, Bryony E. / Evans, Marc / Haskins‐Coulter, Tao / O'Connor, Molly / Cant, Harriet E. O. / Eddowes, Lucy A. / Edmonds, Christopher / Tank, Amarjeet et al. | 2020
- 46
-
Dedicated kidney disease‐focused outcome trials with sodium‐glucose cotransporter‐2 inhibitors: Lessons from CREDENCE and expectations from DAPA‐HF, DAPA‐CKD, and EMPA‐KIDNEYRhee, Jinnie J. / Jardine, Meg J. / Chertow, Glenn M. / Mahaffey, Kenneth W. et al. | 2020
- 51
-
Effects of sitagliptin on gastric emptying of, and the glycaemic and blood pressure responses to, a carbohydrate meal in type 2 diabetesStevens, Julie E. / Buttfield, Madeline / Wu, Tongzhi / Hatzinikolas, Seva / Pham, Hung / Lange, Kylie / Rayner, Christopher K. / Horowitz, Michael / Jones, Karen L. et al. | 2020
- 55
-
What have we learned about renal protection from the cardiovascular outcome trials and observational analyses with SGLT2 inhibitors?Sridhar, Vikas S. / Rahman, Habib U. / Cherney, David Z.I. et al. | 2020
- 59
-
Identifying routine clinical predictors of non‐adherence to second‐line therapies in type 2 diabetes: A retrospective cohort analysis in a large primary care databaseShields, Beverley M. / Hattersley, Andrew T. / Farmer, Andrew J. et al. | 2020
- 66
-
Glycaemic control in patients with type 2 diabetes initiating second‐line therapy: Results from the global DISCOVER study programmeKhunti, Kamlesh / Chen, Hungta / Cid‐Ruzafa, Javier / Fenici, Peter / Gomes, Marilia B. / Hammar, Niklas / Ji, Linong / Kosiborod, Mikhail / Pocock, Stuart / Shestakova, Marina V. et al. | 2020
- 69
-
Non‐steroidal mineralocorticoid antagonists: Prospects for renoprotection in diabetic kidney diseaseAl Dhaybi, Omar / Bakris, George L. et al. | 2020
- 79
-
Association of total sedentary behaviour and television viewing with risk of overweight/obesity, type 2 diabetes and hypertension: A dose–response meta‐analysisGuo, Chunmei / Zhou, Qionggui / Zhang, Dongdong / Qin, Pei / Li, Quanman / Tian, Gang / Liu, Dechen / Chen, Xu / Liu, Leilei / Liu, Feiyan et al. | 2020
- 91
-
Safety and pharmacokinetics of naringenin: A randomized, controlled, single‐ascending‐dose clinical trialRebello, Candida J. / Beyl, Robbie A. / Lertora, Juan J. L. / Greenway, Frank L. / Ravussin, Eric / Ribnicky, David M. / Poulev, Alexander / Kennedy, Brandon J. / Castro, Hector F. / Campagna, Shawn R. et al. | 2020
- 99
-
Hormone‐substrate changes with exenatide plus dapagliflozin versus each drug alone: The randomized, active‐controlled DURATION‐8 studyFerrannini, Ele / Baldi, Simona / Frías, Juan P. / Guja, Cristian / Hardy, Elise / Repetto, Enrico / Jabbour, Serge A. / DeFronzo, Ralph A. et al. | 2020
- 107
-
Comparison of lixisenatide in combination with basal insulin vs other insulin regimens for the treatment of patients with type 2 diabetes inadequately controlled by basal insulin: Systematic review, network meta‐analysis and cost‐effectiveness analysisMen, Peng / Qu, Shuli / Luo, Wenting / Li, Chaoyun / Zhai, Suodi et al. | 2020
- 116
-
Striatal dopamine transporter changes after glucose loading in humansPak, Kyoungjune / Seo, Seongho / Kim, Keunyoung / Lee, Myung Jun / Shin, Myung Jun / Suh, Sunghwan / Im, Hyung‐Jun / Park, Jung‐Jun / Kim, Seong‐Jang / Kim, In Joo et al. | 2020
- 123
-
Efficacy and safety of gemigliptin as add‐on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study)Cho, Young Min / Deerochanawong, Chaicharn / Seekaew, Samroeng / Suraamornkul, Swangjit / Benjachareonwong, Sunun / Sattanon, Sarinya / Chamnan, Parinya / Sirirak, Thanitha / Kosachunhanun, Natapong / Pratipanawatr, Thongchai et al. | 2020
- 128
-
Effects of sodium‐glucose co‐transporter‐2 inhibitors on serum alanine aminotransferase levels in people with type 2 diabetes: A multi‐institutional cohort studyShao, Shih‐Chieh / Chang, Kai‐Cheng / Chien, Rong‐Nan / Lin, Swu‐Jane / Hung, Ming‐Jui / Chan, Yuk‐Ying / Kao Yang, Yea‐Huei / Lai, Edward Chia‐Cheng et al. | 2020
- 135
-
News and Views January 2020: Highlights from the European Association of the Study of Diabetes (EASD) Scientific Meeting 2019Idris, Iskandar et al. | 2020
- 141
-
Mechanism of glucose‐lowering by metformin in type 2 diabetes: Role of bile acidsSansome, Daniel J. / Xie, Cong / Veedfald, Simon / Horowitz, Michael / Rayner, Christopher K. / Wu, Tongzhi et al. | 2020
- 149
-
Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti‐hyperglycaemic drug matters?Giugliano, Dario / Ceriello, Antonio / De Nicola, Luca / Perrone‐Filardi, Pasquale / Cosentino, Francesco / Esposito, Katherine et al. | 2020
- 158
-
Efficacy of metformin in preventing progression to diabetes in a Chinese population with impaired glucose regulation: Protocol for a multicentre, open‐label, randomized controlled clinical studyJi, Linong / Sun, Ningling / Zhang, Yunliang / Zhang, Lihui / Shen, Sheng'ai / Wang, Xueying / Li, Qiuyun / Dong, Luling / Ren, Weidong / Qi, Lin et al. | 2020
- 167
-
Trends in antidiabetic drug utilization and expenditure in Denmark: A 22‐year nationwide studyBang, Camilla / Mortensen, Martin B. / Lauridsen, Kasper G. / Bruun, Jens M. et al. | 2020
- 173
-
Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open‐label, active‐controlled, 12‐week study (STABLE II study)Kwak, Soo Heon / Hwang, You‐Cheol / Won, Jong Chul / Bae, Ji Cheol / Kim, Hyun Jin / Suh, Sunghwan / Lee, Eun Young / Lee, Subin / Kim, Sang‐Yong / Kim, Jae Hyeon et al. | 2020
- 182
-
Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational studyZabala, Alexander / Darsalia, Vladimer / Holzmann, Martin J. / Franzén, Stefan / Svensson, Ann‐Marie / Eliasson, Björn / Patrone, Cesare / Nyström, Thomas / Jonsson, Magnus et al. | 2020
- 191
-
Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium‐glucose co‐transporter‐2, in people with type 2 diabetes mellitusZhang, Hong / Zhu, Xiaoxue / Li, Xiaojiao / Chen, Hong / Wu, Min / Li, Cuiyun / Liu, Jingrui / Liu, Chengjiao / Zhang, Yingjun / Ding, Yanhua et al. | 2020
- 203
-
Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trialsMannucci, Edoardo / Dicembrini, Ilaria / Nreu, Besmir / Monami, Matteo et al. | 2020
- 212
-
Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp studyAberer, Felix / Pferschy, Peter N. / Tripolt, Norbert J. / Sourij, Caren / Obermayer, Anna M / Prüller, Florian / Novak, Eva / Reitbauer, Philipp / Kojzar, Harald / Prietl, Barbara et al. | 2020
- 222
-
Basal insulin secretion capacity predicts the initial response and maximum levels of beta‐hydroxybutyrate during therapy with the sodium‐glucose co‐transporter‐2 inhibitor tofogliflozin, in relation to weight lossSato, Yuichi / Nunoi, Kiyohide / Kaku, Kohei / Yoshida, Akihiro / Suganami, Hideki et al. | 2020
- 231
-
Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetesGhouse, Jonas / Isaksen, Jonas L. / Skov, Morten W. / Lind, Bent / Svendsen, Jesper H. / Kanters, Jørgen K. / Olesen, Morten S. / Holst, Anders G. / Nielsen, Jonas B. et al. | 2020
- 243
-
Optimal fasting glucose levels with regard to cardiovascular and mortality outcomes in people treated with or without antidiabetic medicationJung, Hae Hyuk / Lee, Sunhwa et al. | 2020
- 254
-
Comparative cardiovascular and hypoglycaemic safety of glimepiride in type 2 diabetes: A population‐based cohort studyDouros, Antonios / Dell'Aniello, Sophie / Yu, Oriana Hoi Yun / Suissa, Samy et al. | 2020
- 263
-
Effects of sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes in women versus menRådholm, Karin / Zhou, Zien / Clemens, Kristin / Neal, Bruce / Woodward, Mark et al. | 2020
- 267
-
Fournier's gangrene in patients with type 2 diabetes using second‐line antidiabetic medicationsPetruski‐Ivleva, Natalia / Schneeweiss, Sebastian / Eapen, Sara / Rajan, Aditya / Jan, Saira et al. | 2020
- 272
-
Fournier's gangrene and sodium‐glucose co‐transporter‐2 inhibitors: A meta‐analysis of randomized controlled trialsSilverii, Giovanni Antonio / Dicembrini, Ilaria / Monami, Matteo / Mannucci, Edoardo et al. | 2020
- 279
-
Risk of cardiovascular events in patients with hypertriglyceridaemia: A review of real‐world evidenceToth, Peter P. / Fazio, Sergio / Wong, Nathan D. / Hull, Michael / Nichols, Gregory A. et al. | 2020
- 290
-
Evidence that the multiflorine‐derived substituted quinazolidine 55P0251 augments insulin secretion and lowers blood glucose via antagonism at α2‐adrenoceptors in miceLehner, Zsuzsanna / Stadlbauer, Karin / Brunmair, Barbara / Adorjan, Immanuel / Genov, Miroslav / Kautzky‐Willer, Alexandra / Scherer, Thomas / Scheinin, Mika / Bauer, Leonhardt / Fürnsinn, Clemens et al. | 2020
- 303
-
Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trialsAroda, Vanita R. / Capehorn, Matthew S. / Chaykin, Louis / Frias, Juan P. / Lausvig, Nanna L. / Macura, Stanislava / Lüdemann, Jörg / Madsbad, Sten / Rosenstock, Julio / Tabak, Omur et al. | 2020
- 315
-
Fasting C‐peptide, a biomarker for hypoglycaemia risk in insulin‐naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mLLandgraf, Wolfgang / Owens, David R. / Frier, Brian M. / Zhang, Mei / Bolli, Geremia B. et al. | 2020
- 324
-
Efficacy of the Diabeloop closed‐loop system to improve glycaemic control in patients with type 1 diabetes exposed to gastronomic dinners or to sustained physical exerciseHanaire, Hélène / Franc, Sylvia / Borot, Sophie / Penfornis, Alfred / Benhamou, Pierre‐Yves / Schaepelynck, Pauline / Renard, Eric / Guerci, Bruno / Jeandidier, Nathalie / Simon, Chantal et al. | 2020
- 335
-
Oral semaglutide for type 2 diabetes: A systematic review and meta‐analysisAvgerinos, Ioannis / Michailidis, Theodoros / Liakos, Aris / Karagiannis, Thomas / Matthews, David R. / Tsapas, Apostolos / Bekiari, Eleni et al. | 2020
- 346
-
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT studyCheng, Alice / Harris, Stewart / Giorgino, Francesco / Seufert, Jochen / Ritzel, Robert / Khunti, Kamlesh / Lauand, Felipe / Melas‐Melt, Lydie / Westerbacka, Jukka / Bosnyak, Zsolt et al. | 2020
- 355
-
Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER)Matza, Louis S. / Boye, Kristina S. / Stewart, Katie D. / Coyne, Karin S. / Wullenweber, Paula K. / Cutts, Katelyn N. / Jordan, Jessica B. / Wang, Qianqian / Yu, Maria / Currie, Brooke M. et al. | 2020
- 365
-
Efficacy and safety of MYL‐1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch studyBlevins, Thomas C. / Barve, Abhijit / Raiter, Yaron / Aubonnet, Patrick / Athalye, Sandeep / Sun, Bin / Muniz, Rafael et al. | 2020
- 373
-
Effect of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on gluconeogenesis in proximal renal tubulesKim, Jin Hee / Ko, Hae Young / Wang, Hye Jin / Lee, Hyangkyu / Yun, MiJin / Kang, Eun Seok et al. | 2020
- 383
-
Role of endogenous glucagon‐like peptide‐1 enhanced by vildagliptin in the glycaemic and energy expenditure responses to intraduodenal fat infusion in type 2 diabetesXie, Cong / Wang, Xuyi / Jones, Karen L. / Horowitz, Michael / Sun, Zilin / Little, Tanya J. / Rayner, Christopher K. / Wu, Tongzhi et al. | 2020
- 393
-
Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetesGastaldelli, Amalia / Repetto, Enrico / Guja, Cristian / Hardy, Elise / Han, Jenny / Jabbour, Serge A. / Ferrannini, Ele et al. | 2020
- 404
-
Peptide YY (1–36) peptides from phylogenetically ancient fish targeting mammalian neuropeptide Y1 receptors demonstrate potent effects on pancreatic β‐cell function, growth and survivalLafferty, Ryan A. / Tanday, Neil / McCloskey, Andrew / Bompada, Pradeep / De Marinis, Yang / Flatt, Peter R. / Irwin, Nigel et al. | 2020
- 417
-
Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trialSone, Hirohito / Kaneko, Tatsuroh / Shiki, Kosuke / Tachibana, Yoshifumi / Pfarr, Egon / Lee, Jisoo / Tajima, Naoko et al. | 2020
- 427
-
Low‐dose empagliflozin as adjunct‐to‐insulin therapy in type 1 diabetes: A valid modelling and simulation analysis to confirm efficacyPerkins, Bruce A. / Soleymanlou, Nima / Rosenstock, Julio / Skyler, Jay S. / Laffel, Lori M. / Liesenfeld, Karl‐Heinz / Neubacher, Dietmar / Riggs, Matthew M. / Johnston, Curtis K. / Eudy‐Byrne, Rena J. et al. | 2020
- 434
-
Human regular U‐500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID studyGrunberger, George / Bhargava, Anuj / Ly, Trang / Zisser, Howard / Ilag, Liza L. / Malone, James / Fan, Ludi / Zhang, Shuyu / Johnson, Jennal et al. | 2020
- 442
-
Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular riskHusain, Mansoor / Bain, Stephen C. / Jeppesen, Ole K. / Lingvay, Ildiko / Sørrig, Rasmus / Treppendahl, Marianne B. / Vilsbøll, Tina et al. | 2020
- 452
-
Intensive glucose‐lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trialOhkuma, Toshiaki / Zoungas, Sophia / Jun, Min / Lisheng, Liu / Mancia, Giuseppe / Marre, Michel / Rodgers, Anthony / Williams, Bryan / Woodward, Mark / Chalmers, John et al. | 2020
- 458
-
Favourable effect of the sodium‐glucose co‐transporter‐2 inhibitor canagliflozin plus the dipeptidyl peptidase‐4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open‐label, prospective, randomized, parallel‐group comparison trial (the CALMER study)Cho, Kyu Yong / Nomoto, Hiroshi / Nakamura, Akinobu / Kawata, Shinichiro / Sugawara, Hajime / Takeuchi, Jun / Nagai, So / Tsuchida, Kazuhisa / Omori, Kazuno / Yokoyama, Hiroki et al. | 2020
- 463
-
News and Views March 2020Idris, Iskandar et al. | 2020
- 469
-
Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagonThieu, Vivian T. / Mitchell, Beth D. / Varnado, Oralee J. / Frier, Brian M. et al. | 2020
- 480
-
A randomized, double‐blind, placebo‐controlled, pharmacokinetic and pharmacodynamic study of a fixed‐dose combination of phentermine/topiramate in adolescents with obesityHsia, Daniel S. / Gosselin, Nathalie H. / Williams, Jenna / Farhat, Nada / Marier, J. F. / Shih, Winnie / Peterson, Craig / Siegel, Robert et al. | 2020
- 492
-
Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin‐pump‐treated patients with type 1 diabetes: The Lira Pump trial—a randomized, double‐blinded, placebo‐controlled trialDejgaard, Thomas F. / Schmidt, Signe / Frandsen, Christian S. / Vistisen, Dorte / Madsbad, Sten / Andersen, Henrik U. / Nørgaard, Kirsten et al. | 2020
- 501
-
Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12‐week randomized controlled trialVianna, Andre G. D. / Lacerda, Claudio S. / Pechmann, Luciana M. / Polesel, Michelle G. / Marino, Emerson C. / Scharf, Mauro / Detsch, Josiane M. / Marques, Kleber / Sanches, Claudia P. et al. | 2020
- 512
-
A food‐based, low‐energy, low‐carbohydrate diet for people with type 2 diabetes in primary care: A randomized controlled feasibility trialMorris, Elizabeth / Aveyard, Paul / Dyson, Pamela / Noreik, Michaela / Bailey, Clare / Fox, Robin / Jerome, Derek / Tan, Garry D / Jebb, Susan A et al. | 2020
- 521
-
Pharmacokinetic and pharmacodynamic bioequivalence of proposed biosimilar MYL‐1501D with US and European insulin glargine formulations in patients with type 1 diabetes mellitusHeise, Tim / Donnelly, Charles / Barve, Abhijit / Aubonnet, Patrick et al. | 2020
- 530
-
Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS ProgramOhkuma, Toshiaki / Van Gaal, Luc / Shaw, Wayne / Mahaffey, Kenneth W. / de Zeeuw, Dick / Matthews, David R. / Perkovic, Vlado / Neal, Bruce et al. | 2020
- 540
-
Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trialAraki, Eiichi / Watada, Hirotaka / Uchigata, Yasuko / Tomonaga, Osamu / Fujii, Hitomi / Ohashi, Hiroshi / Okabe, Tadashi / Asano, Michiko / Thoren, Fredrik / Kim, Hyosung et al. | 2020
- 549
-
The effects of dapagliflozin on cardio‐renal risk factors in patients with type 2 diabetes with or without renin‐angiotensin system inhibitor treatment: a post hoc analysisScholtes, Rosalie A. / van Raalte, Daniël H. / Correa‐Rotter, Ricardo / Toto, Robert D. / Heerspink, Hiddo J. L. / Cain, Valerie / Sjöström, C. David / Sartipy, Peter / Stefánsson, Bergur V. et al. | 2020
- 557
-
Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trialHulst, Abraham H. / Visscher, Maarten J. / Godfried, Marc B. / Thiel, Bram / Gerritse, Bastiaan M. / Scohy, Thierry V. / Bouwman, R. Arthur / Willemsen, Mark G. A. / Hollmann, Markus W. / Preckel, Benedikt et al. | 2020
- 566
-
A 12‐week, randomized, double‐blind, placebo‐controlled, four‐arm dose‐finding phase 2 study evaluating bexagliflozin as monotherapy for adults with type 2 diabetesHalvorsen, Yuan‐Di / Walford, Geoffrey / Thurber, Tara / Russell, Heidy / Massaro, Monica / Freeman, Mason W. et al. | 2020
- 574
-
Efficacy and safety of ertugliflozin in East/Southeast Asian patients with type 2 diabetes mellitusLiu, Jie / Patel, Shrita / Cater, Nilo B. / Wu, Larry / Huyck, Susan / Terra, Steven G. / Hickman, Anne / Darekar, Amanda / Pong, Annpey / Gantz, Ira et al. | 2020
- 583
-
Long‐term real‐life glycaemic outcomes with a hybrid closed‐loop system compared with sensor‐augmented pump therapy in patients with type 1 diabetesAkturk, Halis Kaan / Giordano, Dominique / Champakanath, Anagha / Brackett, Scott / Garg, Satish / Snell‐Bergeon, Janet et al. | 2020
- 590
-
Persistent whole day meal effects of three dipeptidyl peptidase‐4 inhibitors on glycaemia and hormonal responses in metformin‐treated type 2 diabetesAlsalim, Wathik / Göransson, Olga / Tura, Andrea / Pacini, Giovanni / Mari, Andrea / Ahrén, Bo et al. | 2020
- 599
-
Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal‐related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetesMeier, Juris J. / Menge, Björn A. / Schenker, Nina / Erdmann, Silke / Kahle‐Stephan, Melanie / Schliess, Freimut / Kapitza, Christoph / Nauck, Michael A. et al. | 2020
- 612
-
Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin‐naïve people with type 2 diabetes: The EDITION AP randomized controlled trialJi, Linong / Kang, Eun Seok / Dong, XiaoLin / Li, Ling / Yuan, GuoYue / Shang, Shuhua / Niemoeller, Elisabeth / EDITION AP trial investigators et al. | 2020
- 622
-
Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real‐world study of more than 30 000 patients in a US electronic health record databasePettus, Jeremy H. / Zhou, Fang Liz / Shepherd, Leah / Mercaldi, Katie / Preblick, Ronald / Hunt, Phillip R. / Paranjape, Sachin / Miller, Kellee M. / Edelman, Steven V. et al. | 2020
- 631
-
Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose‐lowering therapy?Inzucchi, Silvio E. / Fitchett, David / Jurišić‐Eržen, Dubravka / Woo, Vincent / Hantel, Stefan / Janista, Christina / Kaspers, Stefan / George, Jyothis T. / Zinman, Bernard / on behalf of the EMPA‐REG OUTCOME® Investigators et al. | 2020
- 640
-
Dual glucagon‐like peptide‐1 receptor/glucagon receptor agonist SAR425899 improves beta‐cell function in type 2 diabetesVisentin, Roberto / Schiavon, Michele / Göbel, Britta / Riz, Michela / Cobelli, Claudio / Klabunde, Thomas / Dalla Man, Chiara et al. | 2020
- 648
-
Effects of treatment with metformin and/or sitagliptin on beta‐cell function and insulin resistance in prediabetic women with previous gestational diabetesDaniele, Giuseppe / Tura, Andrea / Dardano, Angela / Bertolotto, Alessandra / Bianchi, Cristina / Giusti, Laura / Kurumthodathu, Jancy Joseph / Del Prato, Stefano et al. | 2020
- 658
-
Benefits of insulin degludec/liraglutide are maintained even in patients discontinuing sulphonylureas or dipeptidyl peptidase‐4 inhibitors upon initiation of degludec/liraglutide therapy: A post hoc analysis of the DUAL II and DUAL IX trialsJanez, Andrej / Őrsy, Petra / Stachlewska, Karolina / Salvesen‐Sykes, Karen / Billings, Liana K. / Philis‐Tsimikas, Athena et al. | 2020
- 669
-
Real‐world data reveal unmet clinical needs in insulin treatment in Asian people with type 2 diabetes: the Joint Asia Diabetes Evaluation (JADE) RegisterKong, Alice P. S. / Lew, Thomas / Lau, Eric S. H. / Lim, Lee‐Ling / Kesavadev, Jothydev / Jia, Weiping / Sheu, Wayne H.‐H. / Sobrepena, Leorino / Tan, Alexander T. B. / Nguyen, Thy Khue et al. | 2020
- 680
-
Effect of mean HbA1c on the association of HbA1c variability and all‐cause mortality in patients with type 2 diabetesTseng, Juei‐Yu / Chen, Hsin‐Hung / Huang, Kuo‐Chin / Hsu, Sheng‐Pang / Chen, Ching‐Chu et al. | 2020
- 688
-
Increased proportion of time in hybrid closed‐loop “Auto Mode” is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using the MiniMed 670G insulin pumpDuffus, Sara H. / Ta'ani, Zain Al / Slaughter, James C. / Niswender, Kevin D. / Gregory, Justin M et al. | 2020
- 694
-
Evaluation of a near‐infrared light ultrasound system as a non‐invasive blood glucose monitoring deviceMeyhöfer, Svenja / Wilms, Britta / Ihling, Flavia / Windjäger, Anne / Kalscheuer, Hannes / Augustinov, Andrej / Herrmann, Vera / Lehnert, Hendrik / Schmid, Sebastian M. et al. | 2020
- 699
-
Incretin‐based glucose‐lowering medications and the risk of acute pancreatitis and malignancies: a meta‐analysis based on cardiovascular outcomes trialsAbd El Aziz, Mirna / Cahyadi, Oscar / Meier, Juris J. / Schmidt, Wolfgang E. / Nauck, Michael A. et al. | 2020
- 705
-
Twelve‐year trends in pharmacologic treatment of type 2 diabetes among patients with heart failure in the United StatesDawwas, Ghadeer K. / Leonard, Charles E. / Garg, Mahek / Vouri, Scott M. / Smith, Steven M. / Flory, James H. / Genuardi, Michael V. / Park, Haesuk et al. | 2020
- 711
-
When basal insulin is not enough: response to M DavidsonUmpierrez, Guillermo E. / Skolnik, Neil / Dex, Terry / Traylor, Louise / Chao, Jason / Shaefer, Charles et al. | 2020
- 713
-
Comparative effects of lifestyle modification, metformin and exenatide/glargine combination therapy on daily glycaemic fluctuation in the setting of near‐normoglycaemiaRetnakaran, Ravi / Emery, Alexandra et al. | 2020
- 719
-
Second‐generation basal insulins to initiate insulin therapy in type 2 diabetes: A need for clinical evidence before incurring increased costsDavidson, Mayer B. et al. | 2020
- 722
-
The importance of the initial period of basal insulin titration in people with diabetesKhunti, Kamlesh / Giorgino, Francesco / Berard, Lori / Mauricio, Didac / Harris, Stewart B. et al. | 2020
- 734
-
Interplay of adenosine monophosphate‐activated protein kinase/sirtuin‐1 activation and sodium influx inhibition mediates the renal benefits of sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes: A novel conceptual frameworkPacker, Milton et al. | 2020
- 743
-
The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implicationsOwens, David R. / Bolli, Geremia B. et al. | 2020
- 755
-
A hypothesis for why sodium glucose co‐transporter 2 inhibitors have been found to cause genital infection, but not urinary tract infectionFralick, Michael / MacFadden, Derek R. et al. | 2020
- 759
-
Effectiveness and safety of insulin glargine 300 U/mL in insulin‐naïve patients with type 2 diabetes after failure of oral therapy in a real‐world settingPfohl, Martin / Jornayvaz, François R. / Fritsche, Andreas / Pscherer, Stefan / Anderten, Helmut / Pegelow, Katrin / Seufert, Jochen et al. | 2020
- 767
-
Efficacy of 10‐20‐30 training versus moderate‐intensity continuous training on HbA1c, body composition and maximum oxygen uptake in male patients with type 2 diabetes: A randomized controlled trialBaasch‐Skytte, Thomas / Lemgart, Charlotte T. / Oehlenschläger, Mads H. / Petersen, Pernille E. / Hostrup, Morten / Bangsbo, Jens / Gunnarsson, Thomas P. et al. | 2020
- 779
-
The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mLPhilis‐Tsimikas, Athena / Lane, Wendy / Pedersen‐Bjergaard, Ulrik / Wysham, Carol / Bardtrum, Lars / Harring, Signe / Heller, Simon et al. | 2020
- 788
-
Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady‐state concentrationsJones, Karen L. / Huynh, Lian Q. / Hatzinikolas, Seva / Rigda, Rachael S. / Phillips, Liza K. / Pham, Hung T. / Marathe, Chinmay S. / Wu, Tongzhi / Malbert, Charles H. / Stevens, Julie E. et al. | 2020
- 798
-
Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCELIdzerda, Nienke M. A. / Clegg, Lindsay E. / Hernandez, Adrian F. / Bakris, George / Penland, Robert C. / Boulton, David W. / Bethel, M. Angelyn / Holman, Rury R. / Heerspink, Hiddo J. L. et al. | 2020
- 807
-
A placebo‐controlled proof‐of‐concept study of alirocumab on postprandial lipids and vascular elasticity in insulin‐treated patients with type 2 diabetes mellitusBurggraaf, Benjamin / Pouw, Nadine M.C. / Arroyo, Salvador Fernández / van Vark‐van der Zee, Leonie C. / van de Geijn, Gert‐Jan M. / Birnie, Erwin / Huisbrink, Jeannine / van der Zwan, Ellen M. / Mulder, Monique T. / Rensen, Patrick C.N. et al. | 2020
- 817
-
Enrolment criteria for diabetes cardiovascular outcome trials do not inform on generalizability to clinical practice: The case of glucagon‐like peptide‐1 receptor agonistsSciannameo, Veronica / Berchialla, Paola / Orsi, Emanuela / Lamacchia, Olga / Morano, Susanna / Querci, Fabrizio / Consoli, Agostino / Avogaro, Angelo / Fadini, Gian Paolo / the DARWIN‐T2D study et al. | 2020
- 828
-
Durability of glycaemic control in patients with type 2 diabetes after metformin failure: Prognostic model derivation and validation using the DISCOVER studyLing, Suping / Sun, Ping / Zaccardi, Francesco / Khosla, Sajan / Cooper, Andrew / Fenici, Peter / Khunti, Kamlesh et al. | 2020
- 838
-
Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open‐label, randomized controlled trial (BEYOND VII)Ji, Linong / Wan, Hailong / Wen, Binhong / Wang, Xueying / Wang, Junfen / Bian, Rongwen / Pang, Wuyan / Tian, Jian / Wang, Yan / Bian, Fang et al. | 2020
- 847
-
Comparative effects of sulphonylureas, dipeptidyl peptidase‐4 inhibitors and sodium‐glucose co‐transporter‐2 inhibitors added to metformin monotherapy: a propensity‐score matched cohort study in UK primary careWilkinson, Samantha / Williamson, Elizabeth / Pokrajac, Ana / Fogarty, Damian / Stirnadel‐Farrant, Heide / Smeeth, Liam / Douglas, Ian J. / Tomlinson, Laurie A. et al. | 2020
- 857
-
Relationship between hypoglycaemia, body mass index and quality of life among patients with type 1 diabetes: Observations from the DEPICT clinical trial programmeGordon, Jason / Beresford‐Hulme, Lee / Bennett, Hayley / Tank, Amarjeet / Edmonds, Christopher / McEwan, Phil et al. | 2020
- 866
-
Gluten‐free diet in children with recent‐onset type 1 diabetes: A 12‐month intervention trialNeuman, Vit / Pruhova, Stepanka / Kulich, Michal / Kolouskova, Stanislava / Vosahlo, Jan / Romanova, Martina / Petruzelkova, Lenka / Obermannova, Barbora / Funda, David P. / Cinek, Ondrej et al. | 2020
- 873
-
A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practiceSesti, Giorgio / Bardtrum, Lars / Dagdelen, Selcuk / Halladin, Natalie / Haluzík, Martin / Őrsy, Petra / Rodríguez, Martin / Aroda, Vanita R. et al. | 2020
- 879
-
Comparison of the glucagon‐like‐peptide‐1 receptor agonists dulaglutide and liraglutide for the management of diabetes in solid organ transplant: A retrospective studySingh, Priyamvada / Taufeeq, Maryam / Pesavento, Todd E. / Washburn, Kenneth / Walsh, Debbie / Meng, Shumei et al. | 2020
- 885
-
News and Views May 2020Idris, Iskandar et al. | 2020
- 891
-
Effectiveness of herbal medicines for weight loss: A systematic review and meta‐analysis of randomized controlled trialsMaunder, Alison / Bessell, Erica / Lauche, Romy / Adams, Jon / Sainsbury, Amanda / Fuller, Nicholas R. et al. | 2020
- 904
-
Metformin and cardiorenal outcomes in diabetes: A reappraisalPetrie, John R. / Rossing, Peter R. / Campbell, Ian W. et al. | 2020
- 916
-
Exposure–response relationships for the sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin with regard to renal risk markersKroonen, Marjolein Y. A. M. / Koomen, Jeroen V. / Petrykiv, Sergei I. / Laverman, Gozewijn D. / Heerspink, Hiddo J. L. / Stevens, Jasper et al. | 2020
- 922
-
Changes in the utilization of blood glucose test strips among patients using intermittent‐scanning continuous glucose monitoring in Germanyvan den Boom, Louisa / Kostev, Karel et al. | 2020
- 929
-
Liraglutide as add‐on to sodium‐glucose co‐transporter‐2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA‐ADD2SGLT2i, a 26‐week, randomized, double‐blind, placebo‐controlled trialBlonde, Lawrence / Belousova, Lidia / Fainberg, Udi / Garcia‐Hernandez, Pedro A. / Jain, Sunil M. / Kaltoft, Margit S. / Mosenzon, Ofri / Nafach, Jalal / Palle, Mads Sundby / Rea, Rosangela et al. | 2020
- 938
-
Efficacy and tolerability of tirzepatide, a dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes: A 12‐week, randomized, double‐blind, placebo‐controlled study to evaluate different dose‐escalation regimensFrias, Juan Pablo / Nauck, Michael A. / Van, Joanna / Benson, Charles / Bray, Ross / Cui, Xuewei / Milicevic, Zvonko / Urva, Shweta / Haupt, Axel / Robins, Deborah A. et al. | 2020
- 947
-
Association of increased hepatic insulin clearance and change in serum triglycerides or β‐hydroxybutyrate concentration via the sodium/glucose‐cotransporter 2 inhibitor tofogliflozinMatsubayashi, Yasuhiro / Yoshida, Akihiro / Suganami, Hideki / Osawa, Taeko / Furukawa, Kazuo / Suzuki, Hiroshi / Fujihara, Kazuya / Tanaka, Shiro / Kaku, Kohei / Sone, Hirohito et al. | 2020
- 957
-
Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add‐on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel‐design, open‐label, Phase 3 trialVilsbøll, Tina / Ekholm, Ella / Johnsson, Eva / Garcia‐Sanchez, Ricardo / Dronamraju, Nalina / Jabbour, Serge A. / Lind, Marcus et al. | 2020
- 969
-
Impact of dose‐escalation schemes and drug discontinuation on weight loss outcomes with liraglutide 3.0 mg: A model‐based approachPapathanasiou, Theodoros / Strathe, Anders / Agersø, Henrik / Lund, Trine Meldgaard / Overgaard, Rune Viig et al. | 2020
- 978
-
Effect of adding vildagliptin to insulin in haemodialysed patients with type 2 diabetes: The VILDDIAL study, a randomized, multicentre, prospective studyMunch, Marion / Meyer, Laurent / Hannedouche, Thierry / Kunz, Kristian / Alenabi, Farideh / Winiszewski, Patrice / Baltzinger, Philippe / Smagala, Agnès / Klein, Alexandre / Dorey, François et al. | 2020
- 988
-
The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well‐controlled plasma LDL cholesterolBouter, Kristien E. C. / van Bommel, Erik J. M. / Jansen, Hans / van Harskamp, Dewi / Schierbeek, Henk / Ackermans, Mariëtte T. / Serlie, Mireille J. / Schimmel, Alinda W. M. / Nieuwdorp, Max / Dallinga‐Thie, Geesje M. et al. | 2020
- 997
-
Early and late C‐peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody‐positive individualsIsmail, Heba M. / Becker, Dorothy J. / Libman, Ingrid / Herold, Kevan C. / Redondo, Maria J. / Atkinson, Mark A. / Cleves, Mario A. / Palmer, Jerry / Sosenko, Jay / Diabetes Prevention Trial‐Type 1 (DPT‐1) Study Group et al. | 2020
- 1001
-
Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysisKatsiki, Niki / Ofori‐Asenso, Richard / Ferrannini, Ele / Mazidi, Mohsen et al. | 2020
- 1006
-
Corrigendum| 2020
- 1009
-
Impact of obesity on the increasing incidence of type 1 diabetesBuzzetti, Raffaella / Zampetti, Simona / Pozzilli, Paolo et al. | 2020
- 1014
-
Evidence‐based treatment of hyperglycaemia with incretin therapies in patients with type 2 diabetes and advanced chronic kidney diseaseTuttle, Katherine R. / McGill, Janet B. et al. | 2020
- 1024
-
Sodium‐glucose linked transporter‐2 inhibitor renal outcome modification in type 2 diabetes: Evidence from studies in patients with high or low renal riskSchernthaner, Guntram / Groop, Per‐Henrik / Kalra, Philip A. / Ronco, Claudio / Taal, Maarten W. et al. | 2020
- 1035
-
Efficacy and tolerability of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A systematic review and network meta‐analysisHussein, Humaira / Zaccardi, Francesco / Khunti, Kamlesh / Davies, Melanie J. / Patsko, Emily / Dhalwani, Nafeesa N. / Kloecker, David E. / Ioannidou, Ekaterini / Gray, Laura J. et al. | 2020
- 1047
-
Cost‐effectiveness of dapagliflozin as an adjunct to insulin for the treatment of type 1 diabetes mellitus in the United KingdomBennett, Hayley / Tank, Amarjeet / Evans, Marc / Bergenheim, Klas / McEwan, Phil et al. | 2020
- 1056
-
Clinical use of a 180‐day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetesIrace, Concetta / Cutruzzolà, Antonio / Nuzzi, Annamaria / Assaloni, Roberta / Brunato, Barbara / Pitocco, Dario / Tartaglione, Linda / Di Molfetta, Sergio / Cignarelli, Angelo / Laviola, Luigi et al. | 2020
- 1062
-
Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo‐controlled CARMELINA® trialCooper, Mark E. / Rosenstock, Julio / Kadowaki, Takashi / Seino, Yutaka / Wanner, Christoph / Schnaidt, Sven / Clark, Douglas / Johansen, Odd Erik / CARMELINA investigators et al. | 2020
- 1074
-
Brain free fatty acid uptake is elevated in morbid obesity, and is irreversible 6 months after bariatric surgery: A positron emission tomography studyRebelos, Eleni / Hirvonen, Jussi / Bucci, Marco / Pekkarinen, Laura / Nyman, Mikko / Hannukainen, Jarna C. / Iozzo, Patricia / Salminen, Paulina / Nummenmaa, Lauri / Ferrannini, Ele et al. | 2020
- 1083
-
Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week, randomized, active‐controlled trialFrias, Juan P. / Gonzalez‐Galvez, Guillermo / Johnsson, Eva / Maaske, Jill / Testa, Marcia A. / Simonson, Donald C. / Dronamraju, Nalina / Garcia‐Sanchez, Ricardo / Peters, Anne L. et al. | 2020
- 1094
-
Dapagliflozin plus saxagliptin add‐on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetesJohansson, Lars / Hockings, Paul D. / Johnsson, Eva / Dronamraju, Nalina / Maaske, Jill / Garcia‐Sanchez, Ricardo / Wilding, John P. H. et al. | 2020
- 1102
-
Dose‐dependent reduction in body weight with LIK066 (licogliflozin) treatment in Japanese patients with obesityYokote, Koutaro / Sano, Misako / Tsumiyama, Isao / Keefe, Deborah et al. | 2020
- 1111
-
A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetesCurtin, Francois / Champion, Bernard / Davoren, Peter / Duke, Sally / Ekinci, Elif I. / Gilfillan, Chris / Morbey, Claire / Nathow, Thomas / O'Moore‐Sullivan, Trisha / O'Neal, David et al. | 2020
- 1122
-
Cardiovascular and renal benefits of dapagliflozin in patients with short and long‐standing type 2 diabetes: Analysis from the DECLARE‐TIMI 58 trialBajaj, Harpreet S. / Raz, Itamar / Mosenzon, Ofri / Murphy, Sabina A. / Rozenberg, Aliza / Yanuv, Ilan / Bhatt, Deepak L. / Leiter, Lawrence A. / McGuire, Darren K. / Wilding, John P. H. et al. | 2020
- 1132
-
Incidence of lower extremity amputations among patients with type 1 and type 2 diabetes in the United States from 2010 to 2014Déruaz‐Luyet, Anouk / Raabe, Christina / Garry, Elizabeth M. / Brodovicz, Kimberly G. / Lavery, Lawrence A. et al. | 2020
- 1141
-
Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA‐REG OUTCOME trialVerma, Subodh / Sharma, Abhinav / Zinman, Bernard / Ofstad, Anne Pernille / Fitchett, David / Brueckmann, Martina / Wanner, Christoph / Zwiener, Isabella / George, Jyothis T. / Inzucchi, Silvio E. et al. | 2020
- 1151
-
Can the cardiovascular risk reductions observed with empagliflozin in the EMPA‐REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?Coleman, Ruth L. / Gray, Alastair M. / Broedl MD, Uli C. / Fitchett, David / George, Jyothis T. / Woerle, Hans J. / Zinman, Bernard / Holman, Rury R. et al. | 2020
- 1157
-
A metabolomics‐based molecular pathway analysis of how the sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetesMulder, Skander / Hammarstedt, Ann / Nagaraj, Sunil B. / Nair, Viji / Ju, Wenjun / Hedberg, Jonatan / Greasley, Peter J. / Eriksson, Jan W. / Oscarsson, Jan / Heerspink, Hiddo J. L. et al. | 2020
- 1167
-
Nasal glucagon as a viable alternative for treating insulin‐induced hypoglycaemia in Japanese patients with type 1 or type 2 diabetes: A phase 3 randomized crossover studyMatsuhisa, Munehide / Takita, Yasushi / Nasu, Risa / Nagai, Yukiko / Ohwaki, Kenji / Nagashima, Hirotaka et al. | 2020
- 1176
-
Efficacy and safety of once‐monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo‐controlled, 16‐week randomized dose‐finding studyDel Prato, Stefano / Kang, Jahoon / Trautmann, Michael E. / Stewart, John / Sorli, Christopher H. / Derwahl, Michael / Soto, Alfonso / Yoon, Kun‐Ho et al. | 2020
- 1187
-
A randomized, open‐label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetesWebb, David R. / Htike, Zin Zin / Swarbrick, Daniel J. / Brady, Emer M. / Gray, Laura J. / Biglands, John / Gulsin, Gaurav S. / Henson, Joseph / Khunti, Kamlesh / McCann, Gerry P. et al. | 2020
- 1197
-
Effectiveness of sodium‐glucose co‐transporter‐2 inhibitors on ischaemic heart diseaseShen, Yun / Zhou, Jian / Shi, Lizheng / Nauman, Elizabeth / Katzmarzyk, Peter T. / Price‐Haywood, Eboni G. / Horswell, Ronald / Chu, San / Yang, Shengping / Bazzano, Alessandra N. et al. | 2020
- 1207
-
Association between uric acid levels and cardio‐renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA‐REG OUTCOMEVerma, Subodh / Ji, Qiuhe / Bhatt, Deepak L. / Mazer, C. David / Al‐Omran, Mohammed / Inzucchi, Silvio E. / Wanner, Christoph / Ofstad, Anne Pernille / Zwiener, Isabella / George, Jyothis T. et al. | 2020
- 1215
-
The methionine aminopeptidase 2 inhibitor ZGN‐1061 improves glucose control and weight in overweight and obese individuals with type 2 diabetes: A randomized, placebo‐controlled trialWentworth, John M. / Colman, Peter G. / Zafgen Study Group et al. | 2020
- 1220
-
Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase‐4 inhibitor Linagliptin: A subanalysis from a randomized, placebo‐controlled trial (RELEASE study)de Boer, Stefanie A. / Reijrink, Melanie / Abdulahad, Wayel H. / Hoekstra, Elisa S. / Slart, Riemer H. J. A. / Heerspink, Hiddo J. L. / Westra, Johanna / Mulder, Douwe J. et al. | 2020
- 1226
-
News and Views July 2020Idris, Iskandar et al. | 2020
- 1231
-
Evaluating glucose‐lowering treatment in older people with diabetes: Lessons from the IMPERIUM trialSinclair, Alan J. / Heller, Simon R. / Pratley, Richard E. / Duan, Ran / Heine, Robert J. / Festa, Andreas / Kiljański, Jacek et al. | 2020
- 1243
-
Management of heart failure and type 2 diabetes mellitus: Maximizing complementary drug therapyButler, Javed / Januzzi, James L. / Rosenstock, Julio et al. | 2020
- 1263
-
Efficacy, safety and cardiovascular outcomes of once‐daily oral semaglutide in patients with type 2 diabetes: The PIONEER programmeThethi, Tina K. / Pratley, Richard / Meier, Juris J. et al. | 2020
- 1278
-
Glucose and protein metabolic responses to an energy‐ but not protein‐ restricted diet in type 2 diabetesCoussa, Ayla / Bassil, Maya / Gougeon, Réjeanne / Marliss, Errol B. / Morais, José A. et al. | 2020
- 1286
-
Combined continuous glucose monitoring and subcutaneous insulin infusion versus self‐monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trialDicembrini, Ilaria / Pala, Laura / Caliri, Mariasmeralda / Minardi, Silvia / Cosentino, Claudia / Monami, Matteo / Mannucci, Edoardo et al. | 2020
- 1292
-
Pharmacokinetic and dose‐finding studies on efpeglenatide in patients with type 2 diabetesYoon, Kun‐Ho / Kang, Jahoon / Kwon, Se Chang / Trautmann, Michael E. / Hompesch, Marcus / Stewart, John / Sorli, Christopher H. et al. | 2020
- 1302
-
Development of a three‐dimensional in vitro co‐culture model to increase drug selectivity for humansPark, Sung Bum / Koh, Byumseok / Jung, Won Hoon / Choi, Kyoung Jin / Na, Yoon Ju / Yoo, Hee Min / Lee, Sunray / Kang, Dukjin / Lee, Dong‐Mok / Kim, Ki Young et al. | 2020
- 1316
-
Age‐specific associations of glycated haemoglobin variability with cardiovascular disease and mortality in patients with type 2 diabetes mellitus: A 10‐ year cohort studyWan, Eric Yuk Fai / Yu, Esther Yee Tak / Chin, Weng Yee / Ng, Florence Ting Yan / Chia, Shu Ming Cheryl / Wong, Ian Chi Kei / Chan, Esther Wai Yin / Lam, Cindy Lo Kuen et al. | 2020
- 1328
-
Incretin combination therapy for the treatment of non‐alcoholic steatohepatitisKannt, Aimo / Madsen, Andreas Nygaard / Kammermeier, Claire / Elvert, Ralf / Klöckener, Tim / Bossart, Martin / Haack, Torsten / Evers, Andreas / Lorenz, Katrin / Hennerici, Wolfgang et al. | 2020
- 1339
-
Semaglutide improves health‐related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6)Jódar, Esteban / Michelsen, Marie / Polonsky, William / Réa, Rosangela / Sandberg, Anna / Vilsbøll, Tina / Warren, Mark / Harring, Signe / Ziegler, Uwe / Bain, Stephen et al. | 2020
- 1348
-
Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary diseaseSaeed, Mohamad Isam / Eklöf, Josefin / Achir, Imane / Sivapalan, Pradeesh / Meteran, Howraman / Løkke, Anders / Biering‐Sørensen, Tor / Knop, Filip Krag / Jensen, Jens‐Ulrik Stæhr et al. | 2020
- 1357
-
Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE‐TIMI 58 studyCahn, Avivit / Raz, Itamar / Bonaca, Marc / Mosenzon, Ofri / Murphy, Sabina A. / Yanuv, Ilan / Rozenberg, Aliza / Wilding, John P. H. / Bhatt, Deepak L. / McGuire, Darren K. et al. | 2020
- 1369
-
Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trialHaluzík, Martin / Cheng, Alice / Müller‐Wieland, Dirk / Westerbacka, Jukka / Bosnyak, Zsolt / Lauand, Felipe / Melas‐Melt, Lydie / Karalliedde, Janaka / Rosenstock, Julio / Bolli, Geremia B. et al. | 2020
- 1378
-
Metabolic surgery for the treatment of type 2 diabetes: A network meta‐analysis of randomized controlled trialsCresci, Barbara / Cosentino, Claudia / Monami, Matteo / Mannucci, Edoardo et al. | 2020
- 1388
-
Uric acid predicts long‐term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD studyCao, Jacob Y. / Waldman, Boris / O’Connell, Rachel / Sullivan, David R. / Scott, Russell S. / Aryal, Nanda / Gebski, Val / Marschner, Ian / Taskinen, Marja‐Riitta / Simes, John R. et al. | 2020
- 1397
-
Relationship between improvement of glycaemic control and reduction of major cardiovascular events in 15 cardiovascular outcome trials: A meta‐analysis with meta‐regressionGiugliano, Dario / Bellastella, Giuseppe / Longo, Miriam / Scappaticcio, Lorenzo / Maiorino, Maria Ida / Chiodini, Paolo / Esposito, Katherine et al. | 2020
- 1406
-
Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9‐39) for treatment of post‐bariatric hypoglycaemiaTan, Marilyn / Lamendola, Cynthia / Luong, Roger / McLaughlin, Tracey / Craig, Colleen et al. | 2020
- 1417
-
Effect of liraglutide on food consumption, appetite sensations and eating behaviours in overweight people with type 1 diabetesDubé, Marie‐Christine / D'Amours, Martin / Weisnagel, S. John et al. | 2020
- 1425
-
Association between reduced kidney function and incident hypoglycaemia in people with diabetes: The Stockholm Creatinine Measurements (SCREAM) projectRunesson, Björn / Xu, Yang / Qureshi, Abdul R. / Lindholm, Bengt / Barany, Peter / Elinder, Carl G. / Carrero, Juan J. et al. | 2020
- 1436
-
A pragmatic study of mid‐mixture insulin and basal insulin treatment in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic medications: A lesson from real‐world experienceZhang, Xiaomei / Ma, Yujin / Chen, Hong / Lou, Ying / Ji, Linong / Chen, Lulu et al. | 2020
- 1443
-
The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single‐centre, retrospective, observational study in WuhanZhang, Yang / Li, Haichao / Zhang, Jian / Cao, Yedi / Zhao, Xue / Yu, Nan / Gao, Ying / Ma, Jing / Zhang, Hong / Zhang, Junqing et al. | 2020
- 1455
-
A glycosylated Fc‐fused glucagon‐like peptide‐1 receptor agonist exhibits equivalent glucose lowering to but fewer gastrointestinal side effects than dulaglutideAn, In Bok / Byun, Mi Sun / Yang, Sang In / Choi, Yuri / Woo, Jung Won / Jang, Hak Chul / Sung, Young Chul et al. | 2020
- 1469
-
Bacitracin attenuates haemolysis‐induced insulin degradation during insulin sensitivity testing: Repurposing an old drug for use in metabolic researchDemidowich, Andrew P. / Levine, Jordan A. / Brady, Sheila M. / Johnson, Cheryl D. / Soldin, Steven J. / Yanovski, Jack A. et al. | 2020
- 1474
-
Postprandial hyperglycaemia following insulin suspensions by the artificial pancreas: Implications for bolus calculatorsMajor, Sandrine / El Fathi, Anas / Palisaitis, Emilie / Kearney, Robert / Von Oettingen, Julia E. / Krishnamoorthy, Preetha / Legault, Laurent / Haidar, Ahmad et al. | 2020
- 1481
-
Cardiovascular protection with sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes: Does it apply to all patients?Giorgino, Francesco / Vora, Jiten / Fenici, Peter / Solini, Anna et al. | 2020
- 1496
-
Intermittent fasting and ‘metabolic switch’: Effects on metabolic syndrome, prediabetes and type 2 diabetesRajpal, Aman / Ismail‐Beigi, Faramarz et al. | 2020
- 1511
-
High‐protein diet: A barrier to the nephroprotective effects of sodium‐glucose co‐transporter‐2 inhibitors?Mazzucato, Marta / Fioretto, Paola / Avogaro, Angelo et al. | 2020
- 1516
-
Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT‐2 study): 52‐week results from a randomized controlled trialMathieu, Chantal / Rudofsky, Gottfried / Phillip, Moshe / Araki, Eiichi / Lind, Marcus / Arya, Niki / Thorén, Fredrik / Scheerer, Markus F. / Iqbal, Nayyar / Dandona, Paresh et al. | 2020
- 1527
-
Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study)Kim, Gyuri / Lim, Soo / Kwon, Hyuk‐Sang / Park, Ie B. / Ahn, Kyu J. / Park, Cheol‐Young / Kwon, Su K. / Kim, Hye S. / Park, Seok W. / Kim, Sin G. et al. | 2020
- 1537
-
Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER and SUSTAIN‐6 cardiovascular outcomes trialsKahkoska, Anna R. / Geybels, Milan S. / Klein, Klara R. / Kreiner, Frederik F. / Marx, Nikolaus / Nauck, Michael A. / Pratley, Richard E. / Wolthers, Benjamin O. / Buse, John B. et al. | 2020
- 1548
-
Hyperglucosuria induced by dapagliflozin augments bacterial colonization in the murine urinary tractSaenkham, Panatda / Jennings‐Gee, Jamie / Hanson, Braden / Kock, Nancy D. / Adams, L. Garry / Subashchandrabose, Sargurunathan et al. | 2020
- 1556
-
Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: Pooled analysis of randomized active controlled clinical trialsvan der Aart ‐ van der Beek, Annemarie B. / van Raalte, Daniel H. / Guja, Cristian / Hoogenberg, Klaas / Suchower, Lisa J. / Hardy, Elise / Sjöström, C. David / Heerspink, Hiddo J.L. et al. | 2020
- 1567
-
Impact of disease duration and β‐cell reserve on the efficacy of switching to iGlarLixi in adults with type 2 diabetes on glucagon‐like peptide‐1 receptor agonist therapy: Exploratory analyses from the LixiLan‐G trialDel Prato, Stefano / Frias, Juan Pablo / Blonde, Lawrence / Aroda, Vanita R. / Shehadeh, Niam / Saremi, Aramesh / Dex, Terry / Niemoeller, Elisabeth / Souhami, Elisabeth / Liu, Minzhi et al. | 2020
- 1577
-
Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network (United States) and the prospective diabetes follow‐up (Germany/Austria) registriesShah, Viral N. / Grimsmann, Julia M. / Foster, Nicole C. / Dost, Axel / Miller, Kellee M. / Pavel, Marianne / Weinstock, Ruth S. / Karges, Wolfram / Maahs, David M. / Holl, Reinhard W. et al. | 2020
- 1586
-
Days absent from work as a result of complications associated with type 2 diabetes: Evidence from 20 years of linked national registry data in SwedenPersson, Sofie / Johansen, Pierre / Andersson, Emelie / Lindgren, Peter / Thielke, Desirée / Thorsted, Brian L. / Jendle, Johan / Steen Carlsson, Katarina et al. | 2020
- 1598
-
Positive association of serum uric acid with new‐onset diabetes in Chinese women with hypertension in a retrospective analysis of the China Stroke Primary Prevention TrialZhou, Chun / Liu, Mengyi / Zhang, Zhuxian / Zhang, Yuanyuan / Nie, Jing / Liang, Min / Liu, Chengzhang / Hu, Weimin / Song, Yun / Liu, Lishun et al. | 2020
- 1607
-
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort studyBirkeland, Kåre I. / Bodegard, Johan / Eriksson, Jan W. / Norhammar, Anna / Haller, Hermann / Linssen, Gerard C.M. / Banerjee, Amitava / Thuresson, Marcus / Okami, Suguru / Garal‐Pantaler, Elena et al. | 2020
- 1619
-
Sodium‐glucose co‐transporter‐2 inhibitors and the risk of diabetic ketoacidosis in patients with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trialsLiu, Jiali / Li, Ling / Li, Sheyu / Wang, Yuning / Qin, Xuan / Deng, Ke / Liu, Yanmei / Zou, Kang / Sun, Xin et al. | 2020
- 1628
-
Intrahepatic fat, irrespective of ethnicity, is associated with reduced endogenous insulin clearance and hepatic insulin resistance in obese youths: A cross‐sectional and longitudinal study from the Yale Pediatric NAFLD cohortTricò, Domenico / Galderisi, Alfonso / Mari, Andrea / Polidori, David / Galuppo, Brittany / Pierpont, Bridget / Samuels, Stephanie / Santoro, Nicola / Caprio, Sonia et al. | 2020
- 1639
-
Effect of short‐acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double‐blind placebo‐controlled trialJohansen, Nicklas J. / Dejgaard, Thomas F. / Lund, Asger / Schlüntz, Camilla / Larsen, Emil L. / Poulsen, Henrik E. / Goetze, Jens P. / Møller, Holger J. / Vilsbøll, Tina / Andersen, Henrik U. et al. | 2020
- 1648
-
Sodium‐glucose co‐transporter‐2 inhibitors and the risk of urosepsis: A multi‐site, prevalent new‐user cohort studyFisher, Anat / Fralick, Michael / Filion, Kristian B. / Dell'Aniello, Sophie / Douros, Antonios / Tremblay, Éric / Shah, Baiju R. / Ronksley, Paul E. / Alessi‐Severini, Silvia / Hu, Nianping et al. | 2020
- 1659
-
Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase‐4 inhibitor in Japanese patients with type 2 diabetes: A randomized, 24‐week, open‐label, controlled trial (STOP‐OB)Kitazawa, Toru / Seino, Hiroaki / Ohashi, Hiroshi / Inazawa, Takeshi / Inoue, Masahiro / Ai, Masumi / Fujishiro, Midori / Kuroda, Hisamoto / Yamada, Masayo / Anai, Motonobu et al. | 2020
- 1664
-
Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trialBolli, Geremia B. / Landgraf, Wolfgang / Bosnyak, Zsolt / Melas‐Melt, Lydie / Home, Philip D. et al. | 2020
- 1670
-
Number needed to treat in cardiovascular outcome trials of glucagon‐like peptide‐1 receptor agonists: A systematic review with temporal analysisDavies, Melanie J. / Kloecker, David E. / Webb, David R. / Khunti, Kamlesh / Zaccardi, Francesco et al. | 2020
- 1678
-
Performance of a factory‐calibrated, real‐time continuous glucose monitoring system during elective abdominal surgeryTripyla, Afroditi / Herzig, David / Joachim, Dehais / Nakas, Christos T. / Amiet, Franziska / Andreou, Andreas / Gloor, Beat / Vogt, Andreas / Bally, Lia et al. | 2020
- 1683
-
iGlarLixi effectively reduces residual hyperglycaemia in patients with type 2 diabetes on basal insulin: A post hoc analysis from the LixiLan‐L studyMorea, Nicola / Retnakaran, Ravi / Vidal, Josep / Aroda, Vanita R. / Liu, Minzhi / Saremi, Aramesh / Giorgino, Francesco et al. | 2020
- 1690
-
The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trialsLeiter, Lawrence A. / Bain, Stephen C. / Bhatt, Deepak L. / Buse, John B. / Mazer, C. David / Pratley, Richard E. / Rasmussen, Søren / Ripa, Maria Sejersten / Vrazic, Hrvoje / Verma, Subodh et al. | 2020
- 1696
-
Prevalence of residual inflammatory risk and associated clinical variables in patients with type 2 diabetesPrattichizzo, Francesco / Giuliani, Angelica / Sabbatinelli, Jacopo / Matacchione, Giulia / Ramini, Deborah / Bonfigli, Anna Rita / Rippo, Maria Rita / de Candia, Paola / Procopio, Antonio Domenico / Olivieri, Fabiola et al. | 2020
- 1701
-
In response to the paper ‘High‐protein diet: A barrier to the nephroprotective effects of sodium‐glucose co‐transporter‐2 inhibitors?’León‐Jiménez, David / López‐Mendoza, Manuel / Pérez‐Temprano, Ramón / Górriz, José Luis / Miramontes‐González, José Pablo et al. | 2020
- 1705
-
Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panelConsoli, Agostino / Czupryniak, Leszek / Duarte, Rui / Jermendy, György / Kautzky‐Willer, Alexandra / Mathieu, Chantal / Melo, Miguel / Mosenzon, Ofri / Nobels, Frank / Papanas, Nikolaos et al. | 2020
- 1714
-
Bolus insulin dose depends on previous‐day race intensity during 5 days of professional road‐cycle racing in athletes with type 1 diabetes: A prospective observational studyMoser, Othmar / Dietrich, Marlene / McCarthy, Olivia / Bracken, Richard M. / Eckstein, Max L. et al. | 2020
- 1722
-
Goal achievement of HbA1c and LDL‐cholesterol in a randomized trial comparing colesevelam with ezetimibe: GOAL‐RCTBajaj, Harpreet S. / Brown, Ruth E. / Jiandani, Dishay / Venn, Karri / Al‐Asaad, Hani / Khandwala, Hasnain / Steen, Oren / Abdel‐Salam, Suzan / Aronson, Ronnie et al. | 2020
- 1729
-
A second‐generation glucagon‐like peptide‐1 receptor agonist mitigates vomiting and anorexia while retaining glucoregulatory potency in lean diabetic and emetic mammalian modelsBorner, Tito / Shaulson, Evan D. / Tinsley, Ian C. / Stein, Lauren M. / Horn, Charles C. / Hayes, Matthew R. / Doyle, Robert P. / De Jonghe, Bart C. et al. | 2020
- 1742
-
Liraglutide treatment in overweight and obese patients with type 1 diabetes: A 26‐week randomized controlled trial; mechanisms of weight lossGhanim, Husam / Batra, Manav / Green, Kelly / Abuaysheh, Sanaa / Hejna, Jeanne / Makdissi, Antione / Borowski, Robert / Kuhadiya, Nitesh D. / Chaudhuri, Ajay / Dandona, Paresh et al. | 2020
- 1753
-
The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trialArnott, Clare / Huang, Yuli / Neuen, Brendon L / Di Tanna, Gian Luca / Cannon, Christopher P. / Oh, Richard / Edwards, Robert / Kavalam, Mary / Rosenthal, Norman / Perkovic, Vlado et al. | 2020
- 1767
-
Evaluation of the safety of sodium‐glucose co‐transporter‐2 inhibitors for treating patients with type 1 diabetesWang, Weihao / Zhang, Lina / Pei, Xiaobei / Pan, Qi / Guo, Lixin et al. | 2020
- 1777
-
Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10‐year diabetes cohort studyWan, Eric Y. F. / Yu, Esther Y. T. / Chin, Weng Y. / Barrett, Jessica K. / Mok, Anna H. Y. / Lau, Christie S. T. / Wang, Yuan / Wong, Ian C. K. / Chan, Esther W. Y. / Lam, Cindy L. K. et al. | 2020
- 1789
-
Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover studyHeise, Tim / Linnebjerg, Helle / Coutant, David / LaBell, Elizabeth / Zijlstra, Eric / Kapitza, Christoph / Bue‐Valleskey, Juliana / Zhang, Qianyi / Dellva, Mary Anne / Leohr, Jennifer et al. | 2020
- 1799
-
Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26‐week PRONTO‐T1D studyKlaff, Leslie / Cao, Dachuang / Dellva, Mary Anne / Tobian, Janet / Miura, Junnosuke / Dahl, Dominik / Lucas, Jean / Bue‐Valleskey, Juliana et al. | 2020
- 1808
-
Insulin clearance as the major player in the hyperinsulinaemia of black African men without diabetesLadwa, Meera / Bello, Oluwatoyosi / Hakim, Olah / Shojaee‐Moradie, Fariba / Boselli, Linda / Charles‐Edwards, Geoff / Stadler, Marietta / Peacock, Janet L. / Umpleby, Anne Margot / Amiel, Stephanie A. et al. | 2020
- 1818
-
Sex‐specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE‐ON studyOhkuma, Toshiaki / Peters, Sanne A. E. / Jun, Min / Harrap, Stephen / Cooper, Mark / Hamet, Pavel / Poulter, Neil / Chalmers, John / Woodward, Mark / the ADVANCE Collaborative Group et al. | 2020
- 1827
-
Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta‐cell protection in type 1 diabetesCoomans de Brachène, Alexandra / Castela, Angela / Op de Beeck, Anne / Mirmira, Raghavendra G. / Marselli, Lorella / Marchetti, Piero / Masse, Craig / Miao, Wenyan / Leit, Silvana / Evans‐Molina, Carmella et al. | 2020
- 1837
-
No effects of a 6‐week intervention with a glucagon‐like peptide‐1 receptor agonist on pancreatic volume and oedema in obese men without diabetesSvane, Maria S. / Johannesen, Helle H. / Martinussen, Christoffer / Bojsen‐Møller, Kirstine N. / Hansen, Martin Lundsgaard / Hansen, Adam E. / Deacon, Carolyn F. / Hartmann, Bolette / Keller, Sune H. / Klausen, Thomas L. et al. | 2020
- 1847
-
Effects of dipeptidyl peptidase‐4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8‐week, randomized, controlled, double‐blind trialKraaijenhof, Jordan / Muskiet, Marcel H. A. / Tonneijck, Lennart / Ouwens, D. Margriet / Kramer, Mark H. H. / van Raalte, Daniël H. / Smits, Mark M. et al. | 2020
- 1857
-
Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta‐analysisMantsiou, Chrysanthi / Karagiannis, Thomas / Kakotrichi, Panagiota / Malandris, Konstantinos / Avgerinos, Ioannis / Liakos, Aris / Tsapas, Apostolos / Bekiari, Eleni et al. | 2020
- 1869
-
Efficacy and safety of lobeglitazone versus sitagliptin as an add‐on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeksKim, Sin Gon / Kim, Kyoung Jin / Yoon, Kun Ho / Chun, Sung Wan / Park, Kyong Soo / Choi, Kyung Mook / Lim, Soo / Mok, Ji‐Oh / Lee, Hyoung Woo / Seo, Ji A. et al. | 2020
- 1874
-
Donor insulin use predicts beta‐cell function after islet transplantationShapey, Iestyn M. / Summers, Angela / Yiannoullou, Petros / Khambalia, Hussein / Fullwood, Catherine / Hanley, Neil A. / Casey, John / Forbes, Shareen / Rosenthal, Miranda / Johnson, Paul RV et al. | 2020
- 1880
-
Lower risk of severe hypoglycaemia with insulin glargine 300 U/mL versus glargine 100 U/mL in participants with type 1 diabetes: A meta‐analysis of 6‐month phase 3 clinical trialsDanne, Thomas / Matsuhisa, Munehide / Sussebach, Christian / Goyeau, Harmonie / Lauand, Felipe / Niemoeller, Elisabeth / Bolli, Geremia B. et al. | 2020
- 1886
-
The novel dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 (GLP‐1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long‐acting GLP‐1 receptor agonistsUrva, Shweta / Coskun, Tamer / Loghin, Corina / Cui, Xuewei / Beebe, Emily / O'Farrell, Libbey / Briere, Daniel A. / Benson, Charles / Nauck, Michael A. / Haupt, Axel et al. | 2020
- 1892
-
Diabetes, obesity and COVID‐19: A complex interplayVas, Prashanth / Hopkins, David / Feher, Michael / Rubino, Francesco / B. Whyte, Martin et al. | 2020
- 1897
-
Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID‐19Li, Huiqing / Tian, Shenghua / Chen, Ting / Cui, Zhenhai / Shi, Ningjie / Zhong, Xueyu / Qiu, Kangli / Zhang, Jiaoyue / Zeng, Tianshu / Chen, Lulu et al. | 2020
- 1907
-
Influence of diabetes mellitus on the severity and fatality of SARS‐CoV‐2 (COVID‐19) infectionWu, Jing / Zhang, Jingqi / Sun, Xiaohua / Wang, Lijuan / Xu, Yunfang / Zhang, Yuanyuan / Liu, Xingxiang / Dong, Chen et al. | 2020
- 1915
-
Prevalence of co‐morbidities and their association with mortality in patients with COVID‐19: A systematic review and meta‐analysisSingh, Awadhesh K. / Gillies, Clare L. / Singh, Ritu / Singh, Akriti / Chudasama, Yogini / Coles, Briana / Seidu, Sam / Zaccardi, Francesco / Davies, Melanie J. / Khunti, Kamlesh et al. | 2020
- 1925
-
Exposure to dipeptidyl‐peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta‐analysisMorieri, Mario Luca / Bonora, Benedetta Maria / Longato, Enrico / Di Camilo, Barbara / Sparacino, Giovanni / Tramontan, Lara / Avogaro, Angelo / Fadini, Gian Paolo et al. | 2020
- 1935
-
COVID‐19 infection may cause ketosis and ketoacidosisLi, Juyi / Wang, Xiufang / Chen, Jian / Zuo, Xiuran / Zhang, Hongmei / Deng, Aiping et al. | 2020
- 1942
-
Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2 or COVID‐19)Khunti, Sachin / Khunti, Nitisha / Seidu, Samuel / Khunti, Kamlesh et al. | 2020
- 1946
-
Exposure to dipeptidyl‐peptidase‐4 inhibitors and COVID‐19 among people with type 2 diabetes: A case‐control studyFadini, Gian Paolo / Morieri, Mario Luca / Longato, Enrico / Bonora, Benedetta Maria / Pinelli, Silvia / Selmin, Elisa / Voltan, Giacomo / Falaguasta, Daniele / Tresso, Silvia / Costantini, Giorgia et al. | 2020
- 1951
-
Why is hyperglycaemia worsening COVID‐19 and its prognosis?Ceriello, Antonio / De Nigris, Valeria / Prattichizzo, Francesco et al. | 2020
- 1953
-
Body mass index and the risk of COVID‐19 across ethnic groups: Analysis of UK BiobankRazieh, Cameron / Zaccardi, Francesco / Davies, Melanie J. / Khunti, Kamlesh / Yates, Thomas et al. | 2020
- 1955
-
Admission fasting blood glucose predicts 30‐day poor outcome in patients hospitalized for COVID‐19 pneumoniaZhang, Bin / Liu, Shuyi / Zhang, Lu / Dong, Yuhao / Zhang, Shuixing et al. | 2020
- 1961
-
Practical use of insulin degludec/insulin aspart in a multinational setting: beyond the guidelinesMehta, Roopa / Chen, Roger / Hirose, Takahisa / John, Mathew / Kok, Adri / Lehmann, Roger / Unnikrishnan, Ambika Gopalakrishnan / Yavuz, Dilek Gogas / Fulcher, Gregory et al. | 2020
- 1976
-
Rationale, design and baseline characteristics of the Microbiome and Insulin Longitudinal Evaluation Study (MILES)Jensen, Elizabeth T. / Bertoni, Alain G. / Crago, Osa L. / Hoffman, Kristi L. / Wood, Alexis C. / Arzumanyan, Zorayr / Lam, Lok‐Sze Kelvin / Roll, Kathryn / Sandow, Kevin / Wu, Martin et al. | 2020
- 1985
-
Chronic glucokinase activator treatment activates liver Carbohydrate response element binding protein and improves hepatocyte ATP homeostasis during substrate challengeFord, Brian E. / Chachra, Shruti S. / Alshawi, Ahmed / Brennan, Alfie / Harnor, Suzannah / Cano, Celine / Baker, David J. / Smith, David M. / Fairclough, Rebecca J. / Agius, Loranne et al. | 2020
- 1995
-
Insulin glargine 300 U/mL versus first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 12‐month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real‐life clinical trialMeneghini, Luigi / Blonde, Lawrence / Gill, Jasvinder / Dauchy, Arnaud / Bacevicius, Andrius / Strong, Jodi / Bailey, Timothy S. et al. | 2020
- 2004
-
A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the ACHIEVE Control studyMeneghini, Luigi F. / Sullivan, Sean D. / Oster, Gerry / Busch, Robert / Cali, Anna M. G. / Dauchy, Arnaud / Gill, Jasvinder / Bailey, Timothy S. et al. | 2020
- 2013
-
Semaglutide once weekly in people with type 2 diabetes: Real‐world analysis of the Canadian LMC diabetes registry (SPARE study)Brown, Ruth E / Bech, Peter G / Aronson, Ronnie et al. | 2020
- 2021
-
γ‐aminobutyric acid stimulates β‐cell proliferation through the mTORC1/p70S6K pathway, an effect amplified by Ly49, a novel γ‐aminobutyric acid type A receptor positive allosteric modulatorUntereiner, Ashley / Xu, Jie / Bhattacharjee, Alpana / Cabrera, Over / Hu, Cheng / Dai, Feihan F. / Wheeler, Michael B. et al. | 2020
- 2032
-
The effect of mirabegron on energy expenditure and brown adipose tissue in healthy lean South Asian and Europid menNahon, Kimberly J. / Janssen, Laura G. M. / Sardjoe Mishre, Aashley S. D. / Bilsen, Manu P. / van der Eijk, Jari A. / Botani, Kani / Overduin, Lisanne A. / Ruiz, Jonatan R. / Burakiewicz, Jedrzej / Dzyubachyk, Oleh et al. | 2020
- 2045
-
Exenatide extended release in patients with type 1 diabetes with and without residual insulin productionHerold, Kevan C. / Reynolds, Jesse / Dziura, James / Baidal, David / Gaglia, Jason / Gitelman, Stephen E. / Gottlieb, Peter A. / Marks, Jennifer / Philipson, Louis H. / Pop‐Busui, Rodica et al. | 2020
- 2055
-
Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry studyHaider, Karim Sultan / Haider, Ahmad / Saad, Farid / Doros, Gheorghe / Hanefeld, Markolf / Dhindsa, Sandeep / Dandona, Paresh / Traish, Abdulmaged et al. | 2020
- 2069
-
The effect of referral to an open‐group behavioural weight‐management programme on the relative risk of normoglycaemia, non‐diabetic hyperglycaemia and type 2 diabetes: Secondary analysis of the WRAP trialAhern, Amy L. / Griffin, Simon J. / Wheeler, Graham M. / Sharp, Stephen J. / Aveyard, Paul / Boyland, Emma J. / Halford, Jason C. G. / Jebb, Susan A. et al. | 2020
- 2077
-
Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trialMosenzon, Ofri / Bain, Stephen C. / Heerspink, Hiddo J. L. / Idorn, Thomas / Mann, Johannes F. E. / Persson, Frederik / Pratley, Richard E. / Rasmussen, Søren / Rossing, Peter / von Scholten, Bernt Johan et al. | 2020
- 2089
-
Sotagliflozin added to optimized insulin therapy leads to HbA1c reduction without weight gain in adults with type 1 diabetes: A pooled analysis of inTandem1 and inTandem2Rodbard, Helena W. / Giaccari, Andrea / Lajara, Rosemarie / Stewart, John / Strumph, Paul S. / Oliveira, Juliana / Lapuerta, Pablo / Castro, Rita et al. | 2020
- 2097
-
Vitamin D for treatment of non‐alcoholic fatty liver disease detected by transient elastography: A randomized, double‐blind, placebo‐controlled trialLukenda Zanko, Vesna / Domislovic, Viktor / Trkulja, Vladimir / Krznaric‐Zrnic, Irena / Turk‐Wensveen, Tamara / Krznaric, Zeljko / Filipec Kanizaj, Tajana / Radic‐Kristo, Delfa / Bilic‐Zulle, Lidija / Orlic, Lidija et al. | 2020
- 2107
-
Features of oral glucose tolerance tests in patients after Roux‐en‐Y gastric bypass with and without hypoglycaemia symptoms in daily life: It's all about speedMariën, Ilke / De Block, Christophe / Verrijken, An / Van Dessel, Kristof / Peiffer, Frida / Verhaegen, Ann / Hubens, Guy / Van Gaal, Luc / Dirinck, Eveline et al. | 2020
- 2120
-
Impact of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: A randomized clinical trialMontero, Eduardo / López, Mercedes / Vidal, Honorato / Martínez, María / Virto, Leire / Marrero, Jorge / Herrera, David / Zapatero, Antonio / Sanz, Mariano et al. | 2020
- 2133
-
Effect of setmelanotide, a melanocortin‐4 receptor agonist, on obesity in Bardet‐Biedl syndromeHaws, Robert / Brady, Sheila / Davis, Elisabeth / Fletty, Kristina / Yuan, Guojun / Gordon, Gregory / Stewart, Murray / Yanovski, Jack et al. | 2020
- 2141
-
The impact of the glucagon‐like peptide‐1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetesNielsen, Roni / Jorsal, Anders / Tougaard, Rasmus S. / Rasmussen, Jon J. / Schou, Morten / Videbæk, Lars / Gustafsson, Ida / Faber, Jens / Flyvbjerg, Allan / Wiggers, Henrik et al. | 2020
- 2151
-
Benefit/risk profile of dapagliflozin 5 mg in the DEPICT‐1 and ‐2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m2Mathieu, Chantal / Dandona, Paresh / Birkenfeld, Andreas L / Hansen, Troels Krarup / Iqbal, Nayyar / Xu, John / Repetto, Enrico / Scheerer, Markus Florian / Thoren, Fredrik / Phillip, Moshe et al. | 2020
- 2161
-
Normal insulin sensitivity, glucose tolerance, gut incretin and pancreatic hormone responses in adults with atopic dermatitisGether, Lise / Thyssen, Jacob P. / Gyldenløve, Mette / Hartmann, Bolette / Holst, Jens J. / Foghsgaard, Signe / Vilsbøll, Tina / Knop, Filip K. et al. | 2020
- 2170
-
Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon‐like peptide‐1 receptor agonists: a systematic literature review and indirect treatment comparisonHome, Philip D. / Aroda, Vanita R. / Blonde, Lawrence / Guyot, Patricia / Shaunik, Alka / Fazeli, Mir Sohail / Goswami, Hardik / Kalra, Sanjay / Pourrahmat, Mir‐Masoud et al. | 2020
- 2179
-
Insulin glargine/lixisenatide fixed‐ratio combination (iGlarLixi) compared with premix or addition of meal‐time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta‐analysisHome, Philip / Blonde, Lawrence / Kalra, Sanjay / Ji, Linong / Guyot, Patricia / Brulle‐Wohlhueter, Claire / Murray, Erin / Shah, Roshan / Sayre, Toby / Shaunik, Alka et al. | 2020
- 2189
-
Trial of restarting and tolerating metformin (TreatMet)Orloff, Jeremy N. / Touhamy, Samir H. / Truong, Wanda / Casper, Anthony / Shukla, Alpana P. / Igel, Leon I. / Flory, James H. et al. | 2020
- 2193
-
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trialsVerma, Subodh / Bain, Stephen C. / Honoré, Julie Broe / F. E. Mann, Johannes / A. Nauck, Michael / E. Pratley, Richard / Rasmussen, Søren / Sejersten Ripa, Maria / Zinman, Bernard / Buse, John B. et al. | 2020
- 2199
-
Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS ProgramMatthews, David R. / Wysham, Carol / Davies, Melanie / Slee, April / Alba, Maria / Lee, Mary / Perkovic, Vlado / Mahaffey, Kenneth W. / Neal, Bruce et al. | 2020
- 2204
-
Safety concerns of sodium‐glucose co‐transporter‐2 inhibitors in type 1 diabetes: A real‐world study from the perspective of the Food and Drug Administration Adverse Event Reporting SystemZhou, Xiang / Zhou, Yangzhong / Li, Xuemei / Xiao, Xinhua et al. | 2020
- 2209
-
Cardiovascular outcomes trials with glucagon‐like peptide‐1 receptor agonists: A comparison of study designs, populations and resultsPantalone, Kevin M. / Munir, Kashif / Hasenour, Clinton M. / Atisso, Charles M. / Varnado, Oralee J. / Maldonado, Juan M. / Konig, Manige et al. | 2020
- 2227
-
A look to the future in non‐alcoholic fatty liver disease: Are glucagon‐like peptide‐1 analogues or sodium‐glucose co‐transporter‐2 inhibitors the answer?Vincent, Rebecca K. / Williams, David M. / Evans, Marc et al. | 2020
- 2241
-
Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTEHeller, Simon / Lingvay, Ildiko / Marso, Steven P. / Philis‐Tsimikas, Athena / Pieber, Thomas R. / Poulter, Neil R. / Pratley, Richard E. / Hachmann‐Nielsen, Elise / Kvist, Kajsa / Lange, Martin et al. | 2020
- 2248
-
Development of a hypoglycaemia risk score to identify high‐risk individuals with advanced type 2 diabetes in DEVOTEHeller, Simon / Lingvay, Ildiko / Marso, Steven P. / Philis‐Tsimikas, Athena / Pieber, Thomas R. / Poulter, Neil R. / Pratley, Richard E. / Hachmann‐Nielsen, Elise / Kvist, Kajsa / Lange, Martin et al. | 2020
- 2257
-
Effect of cilostazol on carotid plaque volume measured by three‐dimensional ultrasonography in patients with type 2 diabetes: The FANCY studyLee, Dong‐Hwa / Chun, Eun Ju / Moon, Ji Hye / Yun, Han Mi / Lim, Soo et al. | 2020
- 2267
-
The effects of ertugliflozin on β‐cell function: Pooled analysis from four phase 3 randomized controlled studiesGallo, Silvina / Raji, Annaswamy / Calle, Roberto A. / Pong, Annpey / Meyer, Christian et al. | 2020
- 2276
-
Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phase III studiesPratley, Richard / Dagogo‐Jack, Samuel / Charbonnel, Bernard / Patel, Shrita / Hickman, Anne / Liu, Jie / Tarasenko, Lisa / Pong, Annpey / Ellison, Misoo C. / Huyck, Susan et al. | 2020
- 2287
-
Combination therapy with pioglitazone/exenatide improves beta‐cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3‐year follow‐up of the Qatar studyAbdul‐Ghani, Muhammad / Migahid, Osama / Megahed, Ayman / DeFronzo, Ralph A. / Al‐Ozairi, Ebaa / Jayyousi, Amin et al. | 2020
- 2295
-
Real‐world evidence of the effectiveness on glycaemic control of early simultaneous versus later sequential initiation of basal insulin and glucagon‐like peptide‐1 receptor agonistsRosenstock, Julio / Ampudia‐Blasco, Francisco Javier / Lubwama, Robert / Peng, Xuejun Victor / Boss, Anders / Shi, Lizheng / Fonseca, Vivian et al. | 2020
- 2305
-
Genetic variation in lean body mass, changes of appetite and weight loss in response to diet interventions: The POUNDS Lost trialLi, Xiang / Zhou, Tao / Ma, Hao / Heianza, Yoriko / Champagne, Catherine M. / Williamson, Donald A. / Bray, George A. / Sacks, Frank M. / Qi, Lu et al. | 2020
- 2316
-
Pharmacokinetics, pharmacodynamics and tolerability of single and multiple doses of janagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, in Chinese people with type 2 diabetes mellitusLi, Xiaojiao / Zhu, Xiaoxue / Liu, Jingrui / Li, Qianqian / Zhang, Hong / Li, Cuiyun / Wu, Min / Gao, Lei / Wen, He / Li, Xixi et al. | 2020
- 2325
-
Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10‐year diabetes cohort studyWan, Eric YF / Yu, Esther YT / Chen, Julie Y / Wong, Ian CK / Chan, Esther WY / Lam, Cindy LK et al. | 2020
- 2335
-
Consistent effects of empagliflozin on cardiovascular and kidney outcomes irrespective of diabetic kidney disease categories: Insights from the EMPA‐REG OUTCOME trialWanner, Christoph / Inzucchi, Silvio E. / Zinman, Bernard / Koitka‐Weber, Audrey / Mattheus, Michaela / George, Jyothis T. / von Eynatten, Maximilian / Hauske, Sibylle J. / EMPA‐REG OUTCOME Investigators et al. | 2020
- 2348
-
Sodium‐glucose co‐transporter‐2 inhibitors and major adverse limb events: A trial‐level meta‐analysis including 51 713 individualsHuang, Chen‐Yu / Lee, Jen‐Kuang et al. | 2020
- 2356
-
Effects of insulin degludec and insulin glargine U300 on glycaemic stability in individuals with type 1 diabetes: A multicentre, randomized controlled crossover studyMiura, Hiroshi / Sakaguchi, Kazuhiko / Otowa‐Suematsu, Natsu / Yamada, Tomoko / So, Anna / Komada, Hisako / Okada, Yuko / Hirota, Yushi / Tamori, Yoshikazu / Ogawa, Wataru et al. | 2020
- 2364
-
Assessing the cost‐effectiveness of sodium–glucose cotransporter‐2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real‐world evidenceMcEwan, Phil / Bennett, Hayley / Khunti, Kamlesh / Wilding, John / Edmonds, Christopher / Thuresson, Marcus / Wittbrodt, Eric / Fenici, Peter / Kosiborod, Mikhail et al. | 2020
- 2375
-
Efficacy and safety of polyethylene glycol loxenatide as add‐on to metformin in patients with type 2 diabetes: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3b trialGao, Fei / Lv, Xiaofeng / Mo, Zhaohui / Ma, Jianhua / Zhang, Qiu / Yang, Gangyi / Liu, Weijuan / Li, Quanmin / Zhou, Jian / Bao, Yuqian et al. | 2020
- 2384
-
Cardiometabolic risk factor control in black and white people in the United States initiating sodium‐glucose co‐transporter‐2 inhibitors: A real‐world studyMontvida, Olga / Verma, Subodh / Shaw, Jonathan E. / Paul, Sanjoy K. et al. | 2020
- 2398
-
The effect of a low glycaemic index diet on reducing day‐long glycaemia in healthy young adults: A randomized crossover trialHon, Hannah Wing Han / Wong, Tommy Hon Ting / Tse, Iris Mei Ying / Louie, Jimmy Chun Yu et al. | 2020
- 2408
-
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct‐acting antiviral therapy: A prospective studyAdinolfi, Luigi E. / Petta, Salvatore / Fracanzani, Anna L. / Nevola, Riccardo / Coppola, Carmine / Narciso, Vincenzo / Rinaldi, Luca / Calvaruso, Vincenza / Pafundi, Pia Clara / Lombardi, Rosa et al. | 2020
- 2417
-
Comparative effectiveness of gliclazide modified release versus sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetesZaccardi, Francesco / Jacquot, Emmanuelle / Cortese, Viviana / Tyrer, Freya / Seidu, Samuel / Davies, Melanie J. / Khunti, Kamlesh et al. | 2020
- 2427
-
Limited impact of impaired awareness of hypoglycaemia and severe hypoglycaemia on the inflammatory profile of people with type 1 diabetesAli, Namam / Janssen, Anna W. M. / Jaeger, Martin / Van de Wijer, Lisa / van der Heijden, Wouter / ter Horst, Rob / Vart, Priya / van Gool, Alain / Joosten, Leo A. B. / Netea, Mihai G. et al. | 2020
- 2437
-
Amino acids are sensitive glucagon receptor‐specific biomarkers for glucagon‐like peptide‐1 receptor/glucagon receptor dual agonistsLi, Wenyu / Kirchner, Thomas / Ho, George / Bonilla, Fany / D'Aquino, Katharine / Littrell, James / Zhang, Rui / Jian, Wenying / Qiu, Xi / Zheng, Songmao et al. | 2020
- 2451
-
The dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetesWilson, Jonathan M. / Nikooienejad, Amir / Robins, Deborah A. / Roell, William C. / Riesmeyer, Jeffrey S. / Haupt, Axel / Duffin, Kevin L. / Taskinen, Marja‐Riitta / Ruotolo, Giacomo et al. | 2020
- 2460
-
Dietary fibre intake in childhood or adolescence and subsequent health outcomes: A systematic review of prospective observational studiesReynolds, Andrew N. / Diep Pham, Huyen Tran / Montez, Jason / Mann, Jim et al. | 2020
- 2468
-
Beneficial actions of a long‐acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiationTanday, Neil / Irwin, Nigel / Moffett, R. Charlotte / Flatt, Peter R. / O'Harte, Finbarr P. M. et al. | 2020
- 2479
-
Machine‐learning–based early prediction of end‐stage renal disease in patients with diabetic kidney disease using clinical trials dataBelur Nagaraj, Sunil / Pena, Michelle J. / Ju, Wenjun / Heerspink, Hiddo L. / The BEAt‐DKD Consortium et al. | 2020
- 2487
-
Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trialsVerma, Subodh / McGuire, Darren K. / Bain, Stephen C. / Bhatt, Deepak L. / Leiter, Lawrence A. / Mazer, C. David / Monk Fries, Tea / Pratley, Richard E. / Rasmussen, Søren / Vrazic, Hrvoje et al. | 2020
- 2493
-
Effect of once‐weekly exenatide on estimated glomerular filtration rate slope depends on baseline renal risk: A post hoc analysis of the EXSCEL trialvan der Aart‐van der Beek, Annemarie B. / Clegg, Lindsay E. / Penland, Robert C. / Boulton, David W. / Sjöström, C. David / Mentz, Robert J. / Holman, Rury R. / Heerspink, Hiddo J. L. et al. | 2020
- 2499
-
Short‐term intestinal lipase inhibition in normal‐weight individuals does not affect postprandial peptide YY3‐36 and glucagon‐like peptide‐1 levels, hunger or satietyNguyen, Nga N. / Kolobova, Irina / Wolfe, Bruce M. / Purnell, Jonathan Q. et al. | 2020
- 2504
-
Glucagon‐like peptide‐1 receptor agonists and the appropriate measurement of gastric emptyingHorowitz, Michael / Rayner, Christopher K. / Marathe, Chinmay S. / Wu, Tongzhi / Jones, Karen L. et al. | 2020
- 2507
-
COVID‐19, ketoacidosis and new‐onset diabetes: Are there possible cause and effect relationships among them?Gentile, Sandro / Strollo, Felice / Mambro, Andrea / Ceriello, Antonio et al. | 2020
- 2509
-
Role of exendin‐4 in the Gila monster: Further lessons regarding human oral glucagon‐like peptide‐1 therapy?Graham, Galyna V. / McLaughlin, Chris M. / Flatt, Peter R. et al. | 2020
- i
-
Cover Image, Volume 22, Issue 1Pak, Kyoungjune / Seo, Seongho / Kim, Keunyoung / Lee, Myung Jun / Shin, Myung Jun / Suh, Sunghwan / Im, Hyung‐Jun / Park, Jung‐Jun / Kim, Seong‐Jang / Kim, In Joo et al. | 2020
-
Cover Image, Volume 22, Issue 12Miura, Hiroshi / Sakaguchi, Kazuhiko / Otowa‐Suematsu, Natsu / Yamada, Tomoko / So, Anna / Komada, Hisako / Okada, Yuko / Hirota, Yushi / Tamori, Yoshikazu / Ogawa, Wataru et al. | 2020
-
Cover Image, Volume 22, Issue 7Johansson, Lars / Hockings, Paul D. / Johnsson, Eva / Dronamraju, Nalina / Maaske, Jill / Garcia‐Sanchez, Ricardo / Wilding, John P. H. et al. | 2020
-
Cover Image, Volume 22, Issue 3Matza, Louis S. / Boye, Kristina S. / Stewart, Katie D. / Coyne, Karin S. / Wullenweber, Paula K. / Cutts, Katelyn N. / Jordan, Jessica B. / Wang, Qianqian / Yu, Maria / Currie, Brooke M. et al. | 2020
-
Cover Image, Volume 22, Issue 8Park, Sung Bum / Koh, Byumseok / Jung, Won Hoon / Choi, Kyoung Jin / Na, Yoon Ju / Yoo, Hee Min / Lee, Sunray / Kang, Dukjin / Lee, Dong‐Mok / Kim, Ki Young et al. | 2020
-
Cover Image, Volume 22, Issue 11Haws, Robert / Brady, Sheila / Davis, Elisabeth / Fletty, Kristina / Yuan, Guojun / Gordon, Gregory / Stewart, Murray / Yanovski, Jack et al. | 2020
-
Cover Image, Volume 22, Issue 10Svane, Maria S. / Johannesen, Helle H. / Martinussen, Christoffer / Bojsen‐Møller, Kirstine N. / Hansen, Martin Lundsgaard / Hansen, Adam E. / Deacon, Carolyn F. / Hartmann, Bolette / Keller, Sune H. / Klausen, Thomas L. et al. | 2020
-
Cover Image, Volume 22, Issue 5Ji, Linong / Wan, Hailong / Wen, Binhong / Wang, Xueying / Wang, Junfen / Bian, Rongwen / Pang, Wuyan / Tian, Jian / Wang, Yan / Bian, Fang et al. | 2020